Literature DB >> 10602509

HBV transcription repression in response to genotoxic stress is p53-dependent and abrogated by pX.

G Doitsh1, Y Shaul.   

Abstract

Transcription of hepatitis B Virus (HBV), an important risk factor of hepatocellular carcinoma (HCC), is controlled by cellular transcription activators including some of the cellular signaling targets. Consequently, HBV transcription rate changes in response to the cellular physiological conditions. In this report we investigated HBV gene expression and the role of physiological levels of the viral X protein (pX) under cisplatin induced genotoxic stress. We show that under these conditions the RNA level of an HBV mutant which does not express pX is sharply reduced. Studies revealed that transcription repression is responsible for the observed reduction in HBV RNA level. Repression of HBV transcription was obtained only in the p53 proficient cells. Furthermore, HBV transcription rate is recovered by the cotransfected p53 dominant negative plasmid, indicating that p53 is directly responsible for HBV transcription repression. Unexpectedly, p73, the recent p53 homologue, does not repress but rather activates HBV transcription. Interestingly, pX produced either by the HBV genome or by a cotransfected plasmid, relieves the p53 mediated repression. Collectively, these results attribute a physiological role to p53-inactivation by pX, and explain how pX may support HCC development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602509     DOI: 10.1038/sj.onc.1203209

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Occult hepatitis B in blood donors: a description of two cases.

Authors:  Ciro Capezzuto; Eva Franchi; Simona Urbani; Luisa Romanò; Massimo Franchini
Journal:  Blood Transfus       Date:  2010-10       Impact factor: 3.443

2.  Differential effects on apoptosis induction in hepatocyte lines by stable expression of hepatitis B virus X protein.

Authors:  Nicola Fiedler; Ellen Quant; Ludger Fink; Jianguang Sun; Ralph Schuster; Wolfram H Gerlich; Stephan Schaefer
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

3.  Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death.

Authors:  Olivier Leupin; Séverine Bontron; Céline Schaeffer; Michel Strubin
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  p73beta inhibits transcriptional activities of enhancer I and X promoter in hepatitis B virus more efficiently than p73alpha.

Authors:  Zhen-Hua Xu; Mu-Jun Zhao; Tsai-Ping Li
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  p73 overexpression and nuclear accumulation in hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Romy Zemel; Claud Koren; Larisa Bachmatove; Smadar Avigad; Ella Kaganovsky; Elimelech Okon; Ziv Ben-Ari; Franklin Grief; Merav Ben-Yehoyada; Yosef Shaul; Ran Tur-Kaspa
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

6.  Interaction of mutant hepatitis B X protein with p53 tumor suppressor protein affects both transcription and cell survival.

Authors:  Shoba Iyer; John D Groopman
Journal:  Mol Carcinog       Date:  2011-03-22       Impact factor: 4.784

7.  Enhancer I predominance in hepatitis B virus gene expression.

Authors:  Gilad Doitsh; Yosef Shaul
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

8.  High-level expression and large-scale preparation of soluble HBx antigen from Escherichia coli.

Authors:  Dong Liu; Liyun Zou; Wanling Li; Li Wang; Yuzhang Wu
Journal:  Biotechnol Appl Biochem       Date:  2009-09-24       Impact factor: 2.431

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.